- Home
- » Tags
- » Anal cancer
Top View
- Role of Membrane Rafts in Viral Infection Tadanobu Takahashi and Takashi Suzuki*
- Squamous Cell Carcinoma of the Anus in a Patient with Chronic Lymphocytic Leukemia
- Evolution of the Role of Radiotherapy for Anal Cancer
- 7–10 Years 11-12 Years 13-18 Years
- University of Florida Thesis Or Dissertation Formatting
- FACT SHEET Infectious Causes of Cancer KEY MESSAGES • 3.3% Of
- Human Papillomavirus and Related Diseases Report GERMANY
- Practice Parameters for Anal Squamous Neoplasms Scott R
- Viral Oncology: Molecular Biology and Pathogenesis
- Immunotherapy and Gene Therapy for Oncoviruses Infections: a Review
- A Danish Nationwide Cohort Study Mette T
- Family Practice
- 57778-Hiv-Associated-Anal-Cancer.Pdf
- HIV Infection and Cancer in the Era of Highly Active Antiretroviral Therapy (Review)
- Epidemiology of Anal Canal Cancer
- Gastrointestinal Cancer Adenocarcinoma of the Rectum
- Human Papillomavirus and Related Diseases Report GEORGIA
- Research News in Clinical Context Daas in 2015
- Merkel Cell Polyomavirus DNA in Persons Without Merkel Cell
- Beliefs About Anal Cancer Among HIV-Infected Women: Barriers and Motivators to Participation in Research
- Association of Known and Unknown Oncoviruses with External Genital Lesion
- The Discoveries of Human Papilloma Viruses That Cause Cervical Cancer and of Human Immunodeficiency Virus
- Incidence and Predictors of Abnormal Anal Cytology Findings Among HIV-Infected Adults Receiving Contemporary Antiretroviral Therapy
- (5-FU) and IMRT for Anal Cancer Howard
- Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab As a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)
- Incyte Announces Outcome of FDA Oncologic Drugs Advisory
- Download This Topic [PDF]
- Immunization Clinics
- Novan Creates Dedicated Women's Health Business Unit
- Promoting Human Papilloma Virus Vaccine to Prevent Genital Warts and Cancers
- HIV and Cancer
- Fig. 1A
- Specialty Guideline Management
- Human Papillomavirus; Epidemiology and Prevention of Vaccine
- The Merkel Cell Polyomavirus T Antigens Function As Tumor Promoters in Murine Skin
- Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8 381
- Challenges and Consequences of COVID-19 in the Management of Anorectal Cancer: Coming Together Through Social Distancing
- Understanding Anal Cancer a Guide for People Affected by Cancer
- Encapsulated Plasmid DNA Treatment for Human Papillomavirus 16-Associated Anal Dysplasia: a Phase I Study of ZYC1011
- Vaccines for Cancer Survivors: Who, What, When, and Why? Andrea J
- Clinical Value of Squamous Cell Carcinoma Antigen (Sccag) in Anal Cancer – a Single-Center Retrospective Analysis
- Viral Oncology: Molecular Biology and Pathogenesis
- MR Staging of Anal Cancer: What the Radiologist Needs to Know
- Increased Risk of Anal Squamous Cell Carcinoma in HIV-Positive Men with Prior HBV Infection
- Rationale and Design of the Prevent Anal Cancer Self
- Anal Dysplasia Screening: Anal Pap Smear
- Anal Canal Carcinoma (LAAC): Definitive Analysis of the Intergroup ACCORD-03 Trial
- Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer
- Anal Cancer Patients in a Metropolitan Hospital Present Infection with Multiple Oncogenic Viruses
- (NCCN Guidelines®) Anal Carcinoma
- Viruses and Skin Cancer
- HIV Infection and Cancer Risk
- Differential Outcomes Among Immunosuppressed Patients With
- Anal Cancer in Hiv-Positive Patients: State of the Art
- The Promise of Immunotherapy in Anal Squamous Cell Carcinoma: a Novel Approach for an Orphan Disease
- Human Oncoviruses: Mucocutaneous Manifestations, Pathogenesis, Therapeutics, and Prevention
- Infections and Immune Factors in Cancer: the Role of Epidemiology
- Immunize on Time, Every Time
- Treating Anal Cancer After the Cancer Is Found and Staged, Your Cancer Care Team Will Talk with You About Treatment Options
- Understanding Anal Cancer